Can the Serum Endocan Level Be Used as a Biomarker to Predict Subclinical Atherosclerosis in Patients with Prediabetes?


Creative Commons License

Arman Y., Atici A., Altun O., Sarikaya R., Yoldemir S. A., Akarsu M., ...Daha Fazla

Arquivos brasileiros de cardiologia, cilt.119, ss.544-550, 2022 (SCI-Expanded) identifier identifier